Parallel Advisors’s vTv Therapeutics VTVT Stock Holding History
Bought
Maintained
Sold
Other funds holding VTVT
QC
CUAMC
VNA
FFA
SOW
AWM
CA
CIAM
Parallel Advisors's VTVT Position: Q2 2026 in Review
Parallel Advisors held its vTv Therapeutics (VTVT) position steady in Q2 2026 at 38 shares worth $1.43K. The position accounts for ﹤0.01% of the portfolio, ranked #3607.
Parallel Advisors first reported a position in VTVT in Q2 2020 and has held it in 25 quarters since. The position peaked at $4K in Q1 2021. 12 funds tracked by Wall St. Rank hold VTVT as of Q2 2026.
- Parallel Advisors held 38 shares of vTv Therapeutics worth $1.43K as of Q2 2026.
- Parallel Advisors left its vTv Therapeutics share count unchanged in Q2 2026.
- vTv Therapeutics made up ﹤0.01% of Parallel Advisors's portfolio in Q2 2026, its #3607 holding.
- Parallel Advisors first reported a position in vTv Therapeutics in Q2 2020 and has held it in 25 quarters since.
- Parallel Advisors's vTv Therapeutics position peaked at $4K in Q1 2021.
- 12 funds tracked by Wall St. Rank held vTv Therapeutics as of Q2 2026.
Based on Parallel Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.